✦ LIBER ✦

Potent inhibition of respiratory syncytial virus by combination treatment with 2–5A antisense and ribavirin

✍ Scribed by Zan Xu; Mei Kuang; James R. Okicki; Hagen Cramer; Nilabh Chaudhary

Book ID: 113457098
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 449 KB
Volume: 61
Category: Article
ISSN: 0166-3542
DOI: 10.1016/j.antiviral.2003.10.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

2-5A antisense treatment of respiratory

2-5A antisense treatment of respiratory syncytial virus

✍ Douglas W Leaman 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Potent Inhibition of Respiratory Syncyti

Potent Inhibition of Respiratory Syncytial Virus Replication using a 2-5A-Antisense Chimera Targeted to Signals within the Virus Genomic RNA

✍ Mark R. Player, Dale L. Barnard and Paul F. Torrence 📂 Article 📅 1998 🏛 National Academy of Sciences 🌐 English ⚖ 1011 KB

Targeted Therapy of Respiratory Syncytia

Targeted Therapy of Respiratory Syncytial Virus in African Green Monkeys by Intranasally Administered 2-5A Antisense

✍ Douglas W. Leaman; Frank J. Longano; James R. Okicki; Kenneth F. Soike; Paul F. 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 198 KB

2-5A-DNA conjugate inhibition of respira

2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection

✍ D.L Barnard; R.W Sidwell; W Xiao; M.R Player; S.A Adah; P.F Torrence 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Treatment of respiratory syncytial virus

Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience

✍ Dimitris A. Tsitsikas; Heather Oakervee; Jamie D. Cavenagh; John Gribben; Samir 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

R1626 plus peginterferon Alfa-2a provide

R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin

✍ Paul J. Pockros; David Nelson; Eliot Godofsky; Maribel Rodriguez-Torres; Gregory 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 586 KB

R1626, a prodrug of the hepatitis C virus (HCV) RNA polymerase inhibitor R1479, showed time-dependent and dose-dependent reduction of HCV RNA levels in a previous study. The present study evaluated the efficacy and safety of R1626 administered for 4 weeks in combination with peginterferon alfa-2a ؎